Molecular Templates Inc. has filed for Chapter 11 bankruptcy, according to The Street. The company, known for its work in developing cancer treatment drugs, is hoping to restructure.
The company, which is based in Austin, TX, “listed $2.49 million in assets and $29.4 million in debts in its petition filed on April 20, 2025,” per the outlet. Its working with lender K2 Health Ventures in an effort to continue moving forward.
There has been an increase in bankruptcy filings in the biotechnology industry in recent years due to a variety of reasons…